Breaking News Instant updates and real-time market news.

LMT

Lockheed Martin

$292.13

1.72 (0.59%)

17:47
07/31/17
07/31
17:47
07/31/17
17:47

Lockheed Martin awarded $211.2M government contract modification

Lockheed Martin Corp., Lockheed Martin Aeronautics Co., Fort Worth, Texas, is being awarded $211.2M for modification P00017 to a previously awarded cost-plus-fixed-fee, firm-fixed-price contract. This modification provides for the procurement of production non-recurring special tooling and special test equipment that are required to meet current and future F-35 production rates. Work is expected to be completed in May 2021. The Naval Air Systems Command, Patuxent River, Maryland, is the contracting activity.

  • 23

    Aug

LMT Lockheed Martin
$292.13

1.72 (0.59%)

07/19/17
ARGS
07/19/17
NO CHANGE
ARGS
Lockheed Martin price target raised to $320 from $290 at Argus
Argus analyst John Eade increased his price target on Lockheed Martin after the company reported higher than expected Q2 EPS. The analyst notes that U.S. defense spending is rising, while geopolitical tensions are increasing. Calling the stock's valuation attractive, he keeps a Buy rating on the shares.
07/19/17
FBCO
07/19/17
NO CHANGE
Target $300
FBCO
Neutral
Lockheed Martin price target raised to $300 from $280 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Lockheed Martin to $300 from $280 as he expects shares to grind higher with continued earnings growth, perhaps tempered a little by flattish CF largely due to contract timing. He reiterates a Neutral rating on the shares.
07/19/17
WELS
07/19/17
NO CHANGE
WELS
Lockheed Martin weakness overdone, says Wells Fargo
Wells Fargo says that Lockheed Martin's stock dropped after its Q2 results due to disappointment about its 2018 guidance. The firm thinks the decline was overdone, as it expects the stock's P/E to be at least in-line with that of the market, given its belief that U.S. defense budgets are poised to grow. Moreover, Wells says that the company's 2018 guidance actually hasn't changed, and it keeps an Outperform rating on the shares.
04/26/17
ARGS
04/26/17
NO CHANGE
ARGS
Lockheed Martin weakness creates buying opportunity, says Argus
Argus analyst John Eade says that the 3% decline in Lockheed's stock after the company missed Q1 EPS expectations creates a buying opportunity,. The analyst expects the company to benefit from GOP control in DC and he thinks that the stock's valuation is attractive. Eade keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

15:05
08/17/17
08/17
15:05
08/17/17
15:05
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

EPD

Enterprise Products

$25.07

-0.1 (-0.40%)

15:00
08/17/17
08/17
15:00
08/17/17
15:00
Options
Put buyers in Energy Products Partners »

Put buyers in Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$36.84

-2.11 (-5.42%)

14:58
08/17/17
08/17
14:58
08/17/17
14:58
Recommendations
L Brands analyst commentary  »

L Brands not in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

NUE

Nucor

$54.75

-1.98 (-3.49%)

14:58
08/17/17
08/17
14:58
08/17/17
14:58
Syndicate
Breaking Syndicate news story on Nucor »

Nucor files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$29.21

0.03 (0.10%)

, TSRO

Tesaro

$112.99

-1.01 (-0.89%)

14:50
08/17/17
08/17
14:50
08/17/17
14:50
Recommendations
AstraZeneca, Tesaro, Clovis analyst commentary  »

Lynparza labeling could…

AZN

AstraZeneca

$29.21

0.03 (0.10%)

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

CLVS

Clovis

$71.77

-0.11 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

GOOG

Alphabet

$926.96

4.74 (0.51%)

, GOOGL

Alphabet Class A

$944.27

6.19 (0.66%)

14:50
08/17/17
08/17
14:50
08/17/17
14:50
Periodicals
Google piloting data-friendly Search app in Indonesia, TechCrunch reports »

Google is pilot testing a…

GOOG

Alphabet

$926.96

4.74 (0.51%)

GOOGL

Alphabet Class A

$944.27

6.19 (0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Aug

  • 24

    Aug

AMAT

Applied Materials

$44.46

0.58 (1.32%)

14:49
08/17/17
08/17
14:49
08/17/17
14:49
Options
Applied Materials options imply 6.9% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

AZN

AstraZeneca

$29.17

-0.015 (-0.05%)

, CLVS

Clovis

$71.77

-0.11 (-0.15%)

14:44
08/17/17
08/17
14:44
08/17/17
14:44
Hot Stocks
Feuerstein says Lynparza approval shows FDA sees no differences in PARPs »

STAT's Adam…

AZN

AstraZeneca

$29.17

-0.015 (-0.05%)

CLVS

Clovis

$71.77

-0.11 (-0.15%)

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

FSM

Fortuna Silver Mines

$4.49

-0.01 (-0.22%)

14:30
08/17/17
08/17
14:30
08/17/17
14:30
Options
6.5K Fortuna Silver Mines Aug - Sep 4 call spreads for 9c »

6.5K Fortuna Silver Mines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:30
08/17/17
08/17
14:30
08/17/17
14:30
General news
NY Fed's Survey of Primary Dealers showed expectations for December hike »

NY Fed's Survey of…

PCLN

Priceline

$1,855.72

-5.115 (-0.27%)

14:26
08/17/17
08/17
14:26
08/17/17
14:26
Recommendations
Priceline analyst commentary  »

Priceline recent pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAH

Platform Specialty Products

$12.21

-0.345 (-2.75%)

14:25
08/17/17
08/17
14:25
08/17/17
14:25
Options
Platform Specialty Products call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:25
08/17/17
08/17
14:25
08/17/17
14:25
General news
Canada CPI Preview »

Canada CPI Preview:…

TLSYY

Telstra

$17.11

0.585 (3.54%)

14:23
08/17/17
08/17
14:23
08/17/17
14:23
Downgrade
Telstra rating change  »

Telstra downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$57.49

-0.785 (-1.35%)

, XLI

Industrial Select Sector SPDR

$67.77

-0.84 (-1.22%)

14:23
08/17/17
08/17
14:23
08/17/17
14:23
Technical Analysis
Technical View: S&P 500 breaks another support layer »

The S&P 500 (SPX) is…

XLK

Technology Select Sector SPDR

$57.49

-0.785 (-1.35%)

XLI

Industrial Select Sector SPDR

$67.77

-0.84 (-1.22%)

XLY

Consumer Discretionary Sector SPDR

$89.23

-0.9 (-1.00%)

XLF

Financial Select Sector

$24.78

-0.26 (-1.04%)

SPY

SPDR S&P 500 ETF Trust

$244.48

-2.465 (-1.00%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$111.10

-0.48 (-0.43%)

14:18
08/17/17
08/17
14:18
08/17/17
14:18
Hot Stocks
ADP says Pershing presentation contains nothing not already analyzed »

ADP issued a statement in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

$NSD

NASDAQ Market Internals

14:17
08/17/17
08/17
14:17
08/17/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$30.29

-0.01 (-0.03%)

14:16
08/17/17
08/17
14:16
08/17/17
14:16
Hot Stocks
Goodyear Tire names Christopher Helsel Chief Technology Officer »

The Goodyear Tire &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
08/17/17
08/17
14:16
08/17/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USB

U.S. Bancorp

$52.02

-0.83 (-1.57%)

14:15
08/17/17
08/17
14:15
08/17/17
14:15
Options
US Bancorp put volume heavy and directionally bearish »

Bearish flow noted in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 18

    Oct

  • 17

    Jan

14:10
08/17/17
08/17
14:10
08/17/17
14:10
General news
Fed dove Kashkari said Fed would consider the debt ceiling »

Fed dove Kashkari said…

AVGO

Broadcom

$253.42

-0.27 (-0.11%)

, CSCO

Cisco

$32.34

0.25 (0.78%)

14:08
08/17/17
08/17
14:08
08/17/17
14:08
Hot Stocks
FTC approves final order on Broadcom's acquisition of Brocade »

Following a public…

AVGO

Broadcom

$253.42

-0.27 (-0.11%)

CSCO

Cisco

$32.34

0.25 (0.78%)

BRCD

Brocade

$12.24

0.03 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 24

    Aug

  • 06

    Sep

TXMD

TherapeuticsMD

$6.31

0.3718 (6.26%)

14:05
08/17/17
08/17
14:05
08/17/17
14:05
Options
TherapeuticsMD call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

14:02
08/17/17
08/17
14:02
08/17/17
14:02
General news
Trump condemns terror attack in Barcelona, says 'we love you' »

President Trump just…

PFE

Pfizer

$33.13

-0.235 (-0.70%)

14:02
08/17/17
08/17
14:02
08/17/17
14:02
Hot Stocks
Pfizer receives FDA approval for Besponsa for ALL treatment »

Pfizer announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 08

    Sep

  • 08

    Sep

  • 13

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.